These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23207243)

  • 21. Outcome of surgery for colorectal cancer in the presence of peritoneal carcinomatosis.
    Klaver YL; Lemmens VE; de Hingh IH
    Eur J Surg Oncol; 2013 Jul; 39(7):734-41. PubMed ID: 23523316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of cytoreductive surgery alone for the treatment of peritoneal carcinomatosis of colorectal origin. A retrospective analysis with regard to multimodal treatments.
    Scaringi S; Leo F; Canonico G; Batignani G; Ficari F; Tonelli F
    Hepatogastroenterology; 2009; 56(91-92):650-5. PubMed ID: 19621673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases.
    Kianmanesh R; Scaringi S; Sabate JM; Castel B; Pons-Kerjean N; Coffin B; Hay JM; Flamant Y; Msika S
    Ann Surg; 2007 Apr; 245(4):597-603. PubMed ID: 17414609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.
    Sørensen O; Flatmark K; Reed W; Wiig JN; Dueland S; Giercksky KE; Larsen SG
    Eur J Surg Oncol; 2012 Oct; 38(10):969-76. PubMed ID: 22763244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian metastasis is associated with retroperitoneal lymph node relapses in women treated for colorectal peritoneal carcinomatosis.
    Eveno C; Goéré D; Dartigues P; Honoré C; Dumont F; Tzanis D; Benhaim L; Malka D; Elias D
    Ann Surg Oncol; 2013 Feb; 20(2):491-6. PubMed ID: 22956066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer.
    Carmignani CP; Ortega-Perez G; Sugarbaker PH
    Eur J Surg Oncol; 2004 May; 30(4):391-8. PubMed ID: 15063892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update of carcinoembryonic antigen radioimmunotherapy with (131)I-labetuzumab after salvage resection of colorectal liver metastases: comparison of outcome to a contemporaneous control group.
    Liersch T; Meller J; Bittrich M; Kulle B; Becker H; Goldenberg DM
    Ann Surg Oncol; 2007 Sep; 14(9):2577-90. PubMed ID: 17570017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
    da Silva RG; Sugarbaker PH
    J Am Coll Surg; 2006 Dec; 203(6):878-86. PubMed ID: 17116556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.
    El Halabi H; Gushchin V; Francis J; Athas N; Macdonald R; Nieroda C; Studeman K; Sardi A
    Ann Surg Oncol; 2012 Jan; 19(1):110-4. PubMed ID: 21701929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis.
    Elias D; Goéré D; Di Pietrantonio D; Boige V; Malka D; Kohneh-Shahri N; Dromain C; Ducreux M
    Ann Surg; 2008 Mar; 247(3):445-50. PubMed ID: 18376188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical treatment of peritoneal carcinomatosis from well-differentiated digestive endocrine carcinomas.
    Elias D; Sideris L; Liberale G; Ducreux M; Malka D; Lasser P; Duvillard P; Baudin E
    Surgery; 2005 Apr; 137(4):411-6. PubMed ID: 15800487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis.
    Elias D; Benizri E; Di Pietrantonio D; Menegon P; Malka D; Raynard B
    Ann Surg Oncol; 2007 Feb; 14(2):509-14. PubMed ID: 17096054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases.
    Mulsow J; Merkel S; Agaimy A; Hohenberger W
    Br J Surg; 2011 Dec; 98(12):1785-91. PubMed ID: 22034185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes of curative treatment for colorectal liver metastases combined with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastases: a systematic review and meta-analysis of current evidence.
    Zou Y; Chen X; Zhang X; Shen Z; Cai J; Tan Y; Weng J; Rong Y; Lin X
    Int J Hyperthermia; 2020; 37(1):944-954. PubMed ID: 32787474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis.
    Passot G; Vaudoyer D; Cotte E; You B; Isaac S; Noël Gilly F; Mohamed F; Glehen O
    Ann Surg; 2012 Jul; 256(1):125-9. PubMed ID: 22580942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.
    Franko J; Ibrahim Z; Gusani NJ; Holtzman MP; Bartlett DL; Zeh HJ
    Cancer; 2010 Aug; 116(16):3756-62. PubMed ID: 20564081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
    Weber T; Roitman M; Link KH
    Clin Colorectal Cancer; 2012 Sep; 11(3):167-76. PubMed ID: 22397952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
    Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
    Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unresectable peritoneal carcinomatosis from colorectal cancer: a single center experience.
    Hompes D; Boot H; van Tinteren H; Verwaal V
    J Surg Oncol; 2011 Sep; 104(3):269-73. PubMed ID: 21465492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy.
    Klaver YL; Simkens LH; Lemmens VE; Koopman M; Teerenstra S; Bleichrodt RP; de Hingh IH; Punt CJ
    Eur J Surg Oncol; 2012 Jul; 38(7):617-23. PubMed ID: 22572106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.